Early vomiting of mefloquine in children with malaria is not modified by the timing of antipyretic treatment

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 92, Issue 5, 1998, Pages 562-563

  Luxemburger, C ^a,b,c   Van Vugt, M ^a,b,d   Slight, T ^a   Price, R N ^a,b   Chongsuphajaisiddhi, T ^b   Chanthavanich, P ^b   White, N J ^a,b,c   Nosten, F ^a,b,c  

^a SHOKLO MALARIA RESEARCH UNIT   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Antipyresis; Artesunate; Chemotherapy; Children; Malaria; Mefloquine; Paracetamol; Plasmodium falciparum; Thailand; Vomiting

Indexed keywords

ANTIMALARIAL AGENT; ANTIPYRETIC AGENT; MEFLOQUINE;

ADOLESCENT; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFICACY; FEVER; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MALARIA FALCIPARUM; ORAL DRUG ADMINISTRATION; PLASMODIUM FALCIPARUM; RANDOMIZED CONTROLLED TRIAL; THAILAND; TREATMENT FAILURE; VOMITING;

ARTESUNATE; PLASMODIUM FALCIPARUM;

EID: 0031764803     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(98)90916-6     Document Type: Article

References (9)

1. Brandts, C. H., Ndjavé, M., Graninger, W. & Kremsner, P. G. (1997). Effect of paracetamol on parasite clearance time in Plasmodium falciparum malaria. Lancet, 350, 704-709.
2. Luxemburger, C., Price, R. N., Nosten, F., ter Kuile, F. O., Chongsuphajaisiddhi, T. & White, N. J. (1996). Mefloquine in infants and young children. Annals of Tropical Paediatrics, 16, 281-286.
3. Nosten, F., Luxemburger, C., ter Kuile, F. O., Woodrow, C., Pa Eh, J., Chongsuphajaisiddhi, T. & White, N. J. (1994). Treatment of multi-drug resistant Plasmodium falciparum malaria with 3-day artesunate-mefloquine combination. Journal of Infectious Diseases, 170, 971-977.
4. Palmer, K. J., Holliday, S. M. & Brogden, R. N. (1993). Mefloquine: a review of its antimalarial activity, pharmacokinetic properties, and therapeutic efficacy. Drugs, 45, 430-475.
5. Price, R. N., Nosten, F., Luxemburger, C., van Vugt, M., Phaipun, L., Chongsuphajaisiddhi, T. & White, N. J. (1997). Artesunate/mefloquine treatment of multi-drug resistant falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene, 91, 574-577.
6. Slutsker, L. M., Khoromana, C. O., Payne, D., Allen, C. R., Wirima, J. J., Heymann, D. L., Patchen, L. & Steketee, R. W. (1990). Mefloquine therapy for Plasmodium falciparum malaria in children under 5 years of age in Malawi: in vivo/in vitro efficacy and correlation of drug concentration with parasitological outcome. Bulletin of the World Health Organization, 68, 53-59.
7. Ter Kuile, F. O., Luxemburger, C., Nosten, F., Kyaw Lay Thwai, Chongsuphajaisiddhi, T. & White, N. J. (1995a). Predictors of mefloquine treatment failure: a prospective study of 1590 patients with uncomplicated falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene, 89, 660-664.
8. Ter Kuile, F. O., Nosten, F., Luxemburger, C., Kyle, D. E., Teja-Isavatharm, P., Paiphun, L., Price, R. N., Chongsuphajaisiddhi, T. & White, N. J. (1995b). Mefloquine treatment of acute falciparum malaria: a prospective study of non-serious adverse effects in 3673 patients. Bulletin of the World Health Organization, 73, 631-642.
9. Tin, F., Nyunt Hlaing & Lassere, R. (1982). Single-dose treatment of falciparum malaria with mefloquine: field studies with different doses in semi-immune adults and children in Burma. Bulletin of the World Health Organization, 60, 913-917.